FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 131 filers reported holding FIVE PRIME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,818,000 | -81.6% | 74,800 | -91.7% | 0.04% | -57.3% |
| Q4 2020 | $15,310,000 | +9178.8% | 900,000 | +2471.4% | 0.08% | +4000.0% |
| Q3 2020 | $165,000 | -22.5% | 35,000 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $213,000 | -33.0% | 35,000 | -75.0% | 0.00% | -50.0% |
| Q1 2020 | $318,000 | -80.8% | 140,000 | -61.1% | 0.01% | -78.4% |
| Q4 2019 | $1,652,000 | -2.0% | 360,000 | -17.2% | 0.04% | -21.3% |
| Q3 2019 | $1,686,000 | -33.4% | 435,000 | +3.6% | 0.05% | -19.0% |
| Q2 2019 | $2,533,000 | -46.8% | 420,000 | +18.3% | 0.06% | -4.9% |
| Q1 2019 | $4,757,000 | +46.1% | 355,000 | +1.4% | 0.06% | +38.6% |
| Q4 2018 | $3,255,000 | +14.1% | 350,000 | +70.7% | 0.04% | +25.7% |
| Q3 2018 | $2,854,000 | +20.3% | 205,000 | +36.7% | 0.04% | +6.1% |
| Q2 2018 | $2,372,000 | +38.1% | 150,000 | +50.0% | 0.03% | -8.3% |
| Q1 2018 | $1,718,000 | +26.8% | 100,000 | +122.2% | 0.04% | +33.3% |
| Q2 2017 | $1,355,000 | – | 45,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|